Navigation Links
Boston Scientific Announces Agreement With Fukuda Denshi for Distribution of Cardiac Rhythm Management Products in Japan
Date:1/19/2011

NATICK, Mass., Jan. 19, 2011 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced that its subsidiary, Boston Scientific Japan K.K., has reached an agreement with Fukuda Denshi Co., Ltd. to market and sell its cardiac rhythm management (CRM) devices and accessories throughout Japan.  Fukuda Denshi's extensive sales resources, distribution network and service capabilities will complement Boston Scientific's existing sales and marketing organization and allow the Company to reach substantially more accounts and expand the service it offers to its customers in Japan.  Fukuda Denshi will begin distributing Boston Scientific CRM products this quarter.

"We are pleased to reach agreement with Fukuda Denshi to distribute our CRM products in Japan," said Maulik Nanavaty, President of Boston Scientific Japan.  "Our enhanced sales, distribution and service capabilities will help us better serve Japanese physicians and their patients while broadening our reach and growing our market share in this important market.  Fukuda Denshi has been an established player in Japan for more than 70 years, with a proven track record and a long and successful history of delivering results.  We look forward to a successful partnership with them."

Boston Scientific is a leading developer of implantable devices used to treat cardiac arrhythmias (abnormal heart rhythms), sudden cardiac arrest and heart failure.  The Company's advanced product portfolio includes pacemakers, implantable cardioverter defibrillators (ICDs), cardiac resynchronization therapy defibrillators (CRT-Ds), cardiac leads and patient management systems.

About Fukuda DenshiFounded in 1939, Fukuda Denshi is a global leader in the research and development, manufacture and sale of medical electronics equipment.  With corporate headquarters in Tokyo, the company supports
'/>"/>

SOURCE Boston Scientific Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Boston Scientific to Webcast Conference Call Discussing Fourth Quarter and Full Year 2010 Financial Results
2. Boston Scientific to Acquire Atritech
3. Boston Scientific Completes Enrollment in Clinical Trial Evaluating Next-Generation Nitinol Stent to Treat Iliac Artery Disease
4. Statement of Kenneth Stein, M.D., Chief Medical Officer, Cardiac Rhythm Management, Boston Scientific on JAMA Article
5. Boston Scientific Completes Acquisition of Sadra Medical
6. Stryker Completes Acquisition of the Neurovascular Division of Boston Scientific
7. Boston Scientific Completes Sale of Neurovascular Business
8. Boston Scientific to Present at 29th Annual J.P. Morgan Healthcare Conference
9. Boston Scientific Announces Election of Dr. Kristina M. Johnson to its Board of Directors
10. Boston Scientific Welcomes Publication of Analysis of Patients Monitored by the LATITUDE® Patient Management System
11. EvaluatePharma USA, Inc. Welcomed Into Boston Biotech Community by Mayor Menino
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... Research and Markets ( ... "Investigation Report on China,s Ranibizumab Market, 2012-2019" report ... was approved by CFDA to treat wet age- related ... product of Novartis, is available in the Chinese market. ... drug for the treatment of wet AMD in ...
(Date:8/28/2015)... , Aug. 28, 2015 Perrigo Company ... on the Mylan N.V. ("Mylan") (NASDAQ: MYL ) ... Perrigo. "Our views of Mylan,s offer to ... be, based on our Board,s careful reflection of the ... on the limited choices that Mylan has allowed its ...
(Date:8/28/2015)... HERTFORDSHIRE, England and PITTSBURGH ... (NASDAQ: MYL ) today announced that its ... Company plc (NYSE: PRGO ; TASE) and ... Perrigo,s shareholders at an extraordinary general meeting of ... of two-thirds of the votes cast at the extraordinary general ...
Breaking Medicine Technology:Investigation Report on China's Ranibizumab Market, 2012-2019 2Perrigo Confident Its Shareholders Will Reject Mylan's Value Destructive Transaction 2Perrigo Confident Its Shareholders Will Reject Mylan's Value Destructive Transaction 3Perrigo Confident Its Shareholders Will Reject Mylan's Value Destructive Transaction 4Perrigo Confident Its Shareholders Will Reject Mylan's Value Destructive Transaction 5Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 2Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 3Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 4Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 5Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 6Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 7Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 8Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 9
... Inc. (Nasdaq: NLTX ), a biopharmaceutical company ... disease, today announced that Michael R. Bristow, M.D. Ph.D. ... of CD-NP, a dual natriuretic peptide receptor agonist in ... Dr. Bristow, a recognized leader in ...
... Oct. 7 Reportlinker.com announces that a new ... U.S. Venous Access Catheter Market ... This study covers U.S. markets for venous access ... venous catheters (CVCs), dialysis catheters, implantable ports, and ...
Cached Medicine Technology:Michael R. Bristow, M.D. Ph.D. Joins Nile Therapeutics Scientific Advisory Board 2Michael R. Bristow, M.D. Ph.D. Joins Nile Therapeutics Scientific Advisory Board 3Reportlinker Adds U.S. Venous Access Catheter Market 2Reportlinker Adds U.S. Venous Access Catheter Market 3Reportlinker Adds U.S. Venous Access Catheter Market 4
(Date:8/29/2015)... ... August 29, 2015 , ... The popular television program ... Jones, recently announced that it will be devoting an entire short segment to the ... of people around the globe on a daily basis, but recent advancements in medical ...
(Date:8/28/2015)... ... August 28, 2015 , ... Approximately 2,000 United Methodists ... celebrate children helping children, a thank you to the many creative and generous ... to the United Methodist initiative to end malaria deaths. , The Columbus Zoo ...
(Date:8/28/2015)... Falls Church, VA (PRWEB) , ... ... ... and Cybersecurity Risk Management for Medical Devices:, Understanding the FDA’s Position and ... – Rockville, MD, http://www.fdanews.com/cybersecuritymd , This workshop, chaired by internationally ...
(Date:8/28/2015)... (PRWEB) , ... August 28, 2015 , ... ... 20 grams of high grade protein with zero fat, carbs, sugar, gluten, lactose ... been named a finalist for the 2015 SupplySide CPG Editor’s Choice Awards. , ...
(Date:8/28/2015)... ... 28, 2015 , ... The Nashville Business Journal recently announced ... business. Mr. Troy Mizell, Chairman of the Board at MyGenetx, is one ... Veterans Awards will recognize Nashville military veterans who, through their professional and personal ...
Breaking Medicine News(10 mins):Health News:Saturday’s United Methodist Event at Columbus Zoo Celebrates Imagine No Malaria 2Health News:Saturday’s United Methodist Event at Columbus Zoo Celebrates Imagine No Malaria 3Health News:FDAnews Announces — Software and Cybersecurity Risk Management for Medical Devices: Understanding the FDA’s Position and Best Practices for Compliance, Oct. 14-15 2Health News:FDAnews Announces — Software and Cybersecurity Risk Management for Medical Devices: Understanding the FDA’s Position and Best Practices for Compliance, Oct. 14-15 3Health News:FDAnews Announces — Software and Cybersecurity Risk Management for Medical Devices: Understanding the FDA’s Position and Best Practices for Compliance, Oct. 14-15 4Health News:FDAnews Announces — Software and Cybersecurity Risk Management for Medical Devices: Understanding the FDA’s Position and Best Practices for Compliance, Oct. 14-15 5Health News:Pocket Protein™ Named 2015 CPG Editor’s Choice Award Finalist by Informa’s SupplySide 2Health News:Pocket Protein™ Named 2015 CPG Editor’s Choice Award Finalist by Informa’s SupplySide 3Health News:MyGenetx Board Member Receives Veterans Award 2
... illnesses such as diabetes and high blood pressure when ... to a RAND Corporation study issued today. , Even ... new health plan year, a significant number of seniors ... findings published in the September/October edition of the journal ...
... Angeles, Sept. 14, 2007 -- A new study by researchers ... may be good for you. , Researchers found that ... dealt with teen obesity, hypertension and healthy eating habits had ... particularly among men. , The study, published in the Sept. ...
... concern and disappointment about reports that the pending SCHIP ... are critical to access to care for Medicare beneficiaries ... College of Physicians (ACP). David C. Dale, MD, ... the 124,000 internal medicine physicians and medical student members ...
... advance over invasive tests , , FRIDAY, Sept. 21 (HealthDay ... blood could become the lens through which doctors monitor ... study suggests. , "It,s amazing that all these pregnant ... blood," said Dr. Jill L. Maron, the study,s lead ...
... (Nasdaq: ADLS ), has received approval from the ... common stock,to the NASDAQ Capital Market from the NASDAQ ... of the Market today. The Company continues to be,listed ... http://www.newscom.com/cgi-bin/prnh/20050428/CGTH039LOGO ) "Advanced Life Sciences currently meets ...
... will honor,Texas House Speaker Tom Craddick and his wife, ... event that sold out faster and well,exceeded the amount ... participants and sponsors still on its waiting list. ... lent their names to,this important event, proceeds from the ...
Cached Medicine News:Health News:Study finds drug spending caps cause some seniors to quit taking key medicines 2Health News:ER episode impacts viewers' health knowledge and behavior 2Health News:'Deep concern and disappointment' with exclusion of Medicare from SCHIP legislation 2Health News:'Deep concern and disappointment' with exclusion of Medicare from SCHIP legislation 3Health News:Mother's Blood Could Offer Insights Into Fetal Health 2Health News:Mother's Blood Could Offer Insights Into Fetal Health 3Health News:Advanced Life Sciences Joins NASDAQ Capital Market 2Health News:2007 Speaker's Golf Tournament Sets 5-Year Fundraising Record 2
... is a freestanding cryostat with a ... and a radial cutting microtome. It ... wide range of specimens and materials ... in high biohazard risk laboratories where ...
The HM 550 series is a uniquely progressive concept for use with frozen specimens of all types. User applications define module selection and make even serial sectioning enjoyable....
... TP1020 product family are semi-enclosed tissue processors. ... of approved technology with modern and functionally ... safety for tissues at all stages of ... on proven precision mechanics in conjunction with ...
The HMP300 Histo Pro delivers all the features and benefits that conventional tissue processing have to offer....
Medicine Products: